Medical Properties Trust Announces Public Offerings of 10 Million Shares of Common Stock and Senior Notes

Medical Properties Trust, Inc. (the “Company”)

announced today its intention to sell 10,000,000 shares of its common stock in an underwritten public offering. The Company intends to grant the underwriters of the offering a 30-day option to purchase up to an additional 1,500,000 shares of its common stock. Additionally, the Company announced today that its operating partnership, MPT Operating Partnership, L.P. (the “Operating Partnership”), and MPT Finance Corporation, a wholly-owned subsidiary of the Operating Partnership (“MPT Finance”), intend to offer, subject to market and other conditions, $150 million aggregate principal amount of its senior notes due 2022. The notes will be senior unsecured obligations of the Operating Partnership and MPT Finance, guaranteed by the Company and by certain subsidiaries of the Operating Partnership, and will form a part of the same series as the Operating Partnership's and MPT Finance's senior notes due 2022, issued on February 17, 2012, $200 million of which are currently outstanding. The Operating Partnership intends to use the net proceeds from both offerings to fund its previously announced acquisition of three general acute care hospitals from IASIS Healthcare LLC. Pending closing of the acquisition, the Operating Partnership intends to use the net proceeds of the offerings to repay amounts outstanding under its revolving credit facility and to invest in short-term, liquid investments. If the acquisition is not completed, the Operating Partnership intends to use the net proceeds from the offerings to repay borrowings under its revolving credit facility and for general corporate purposes, which may include investing in additional healthcare properties. The consummation of the offering of notes and offering of common stock are not contingent upon each other, and are not contingent upon the closing of the acquisition. BofA Merrill Lynch and J.P. Morgan will act as joint book running managers for the proposed offering of common stock. The offering of common stock will be made under the Company's effective shelf registration statement filed with the Securities and Exchange Commission ("SEC"). The Company intends to file a prospectus supplement with the SEC for the common stock offering. When available, the prospectus supplement and accompanying base prospectus may be obtained from BofA Merrill Lynch, 222 Broadway, New York, NY 10038, Attn: Prospectus Department or by e-mail at dg.prospectus_requests@baml.com or from J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717 or by calling 1-866-803-9204 or by visiting the EDGAR database on the SEC's web site at www.sec.gov. J.P. Morgan and BofA Merrill Lynch will act as joint-book running managers for the proposed offering of senior notes. The offering of senior notes will be made under an effective shelf registration statement of the Company, the Operating Partnership, MPT Finance Corporation and certain subsidiaries as guarantors. The Company intends to file a prospectus supplement with the SEC for the senior notes offering. When available, the prospectus supplement may be obtained from J.P. Morgan Securities LLC, 383 Madison Avenue, 3rd Floor, New York, NY 10179, Attn: Syndicate or from BofA Merrill Lynch, 222 Broadway, New York, NY 10038, Attn: Prospectus Department or by visiting the EDGAR database on the SEC's web site at www.sec.gov.